Researchers design a probiotic to suppress autoimmunity in the brain

Brigham researchers are working on a new approach to target autoimmunity in the brain leverages designer bacteria to make treatment safer and more effective.

Endpoints 11 winner Metsera: Clive Meanwell wagers on obesity after Medicines Company success

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 27, 2024

Surgalign files for bankruptcy, agrees to sell US hardware unit for $5M

Dive Brief: Surgalign has filed for bankruptcy and agreed to sell its U.S. hardware and biomaterials assets to Xtant Medical Holdings for $5 million. After

June 21, 2023

CT scans may be better first step for evaluating chest pain

Previous studies have found less than 40% of patients with stable chest pain undergoing invasive coronary angiography are found to have obstructive coronary artery disease.

February 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.